PTEN hamartoma tumor syndrome
- Q85.81 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- ICD-10-CM Q85.81 is a revised 2024 ICD-10-CM code that became effective on October 1, 2023.
- This is the American ICD-10-CM version of Q85.81 – other international versions of ICD-10 Q85.81 may differ.
Applicable To
- PHTS
- PTEN related Cowden syndrome
Code Also
- , if applicable, genetic susceptibility to malignant neoplasm (Z15.0-)
The following code(s) above Q85.81 contain annotation back-references
that may be applicable to Q85.81:
- Q00-Q99 Congenital malformations, deformations and chromosomal abnormalities
- Q85 Phakomatoses, not elsewhere classified
- Q85.8 Other phakomatoses, not elsewhere classified
Present On Admission
- Q85.81 is considered exempt from POA reporting.
ICD-10-CM Q85.81 is grouped within Diagnostic Related Group(s) (MS-DRG v41.0):
- 826 Myeloproliferative disorders or poorly differentiated neoplasms with major o.r. Procedures with mcc
- 827 Myeloproliferative disorders or poorly differentiated neoplasms with major o.r. Procedures with cc
- 828 Myeloproliferative disorders or poorly differentiated neoplasms with major o.r. Procedures without cc/mcc
- 829 Myeloproliferative disorders or poorly differentiated neoplasms with other procedures with cc/mcc
- 830 Myeloproliferative disorders or poorly differentiated neoplasms with other procedures without cc/mcc
- 843 Other myeloproliferative disorders or poorly differentiated neoplastic diagnoses with mcc
- 844 Other myeloproliferative disorders or poorly differentiated neoplastic diagnoses with cc
- 845 Other myeloproliferative disorders or poorly differentiated neoplastic diagnoses without cc/mcc
Code History
- 2023 (effective 10/1/2022): New code
- 2024 (effective 10/1/2023): Revised code
- New description: PTEN hamartoma tumor syndrome
- 2023 description: PTEN tumor syndrome
Diagnosis Index entries containing back-references to Q85.81: